Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) shot up 0% on Tuesday following a dividend announcement from the company. The stock traded as high as $814.00 and last traded at $803.94.

Eli Lilly and Company (NYSE:LLY – Get Free Report) declared that its Board of Directors has approved a stock buyback program on Monday, December 9th, RTT News reports. The company plans to repurchase ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, ...

The company also announced that its unbranded insulin variety would be priced at $25 per vial starting in ... of its most prescribed insulin brands Humalog and Humulin by 70 percent.